Novel Therapy for Male Hypogonadism
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Purpose of review Hypogonadism and the treatment of low testosterone is increasingly a subject of medical inquiry and controversy. The few treatments that are FDA-approved such as testosterone topicals, injections, and pellets create significant demand from patients for treatments with more convenient means of administration, fewer adverse effects, and the ability to maintain male fertility. Off-label drugs are in abundant use for low testosterone, including selective estrogen receptor modulators, gonadotropins, and aromatase inhibitors.Recent findings In this review, we summarize the evidence in support of commonly used treatments for male hypogonadism, as well as discuss recent updates in the development of novel therapeutics. New therapies include nasal testosterone, new oral testosterone formulations, anabolic-androgenic steroids, and selective androgen receptor modulators.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GnRH therapy must thus be administered in a pulsatile manner by a subcutaneous pump [42,46].”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [46]
In the citing paper
“As the physiological secretion of GnRH is episodic, continuous administration of GnRH leads to desensitization of the pituitary and suppression of gonadotropin secretion.”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [46]
Citations
Cites
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
(2015) · European Journal of Haematology · doi:10.1111/ejh.12636 · Cited by 780
Prevalence of Symptomatic Androgen Deficiency in Men
Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1245 · Cited by 720
Araujo, A. B., O’Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., & McKinlay, J. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031719 · Cited by 591
Transdermal patches: history, development and pharmacology
Pastore, M. N., Kalia, Y. N., Horstmann, M., & Roberts, M. S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13059 · Cited by 586
Pharmacology of anabolic steroids
Kicman, A. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.165 · Cited by 580
Seminara, S. B., Hayes, F. J., & Crowley, W. F. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0344 · Cited by 414
Research works printed but not linked: 2
- Ceponis J, Yadav P, Swerdloff RS, Wang C. Chapter 11: Testosterone therapy: transdermal androgens. Testosterone: from basic to clinical aspects. Springer, 2017.
- Testopel (testosterone pellets). prescribing information. Rye: Slate pharmaceuticals, Inc.; 2013.
Cited by
Selective androgen receptor modulators: the future of androgen therapy?
Christiansen, A. R., Lipshultz, L. I., Hotaling, J. M., & Pastuszak, A. W. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.11.02 · Cited by 155
“In addition to their potential use for the treatment of hypogonadism (7,8), SARMs are being explored as a potential therapy for osteopenia/osteoporosis (9-14), A lzhe imer ’s d i sease (15) , pros ta te cancer (PCa) (16,17), benign prostatic hyperplasia (BPH) (18), male contraception (19), breast cancer (20), stress-i…”
BackgroundSudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review
Torrisi, M., Pennisi, G., Russo, I., Amico, F., Esposito, M., Liberto, A., Cocimano, G., Salerno, M., Rosi, G. L., Nunno, N. R. D., et al. (2020) · Medicina · doi:10.3390/medicina56110587 · Cited by 114
“Direct testosterone replacement therapy (TRT) is the only FDA-approved therapy for the treatment of male hypogonadism [6].”
BackgroundTreatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
Ide, V., Vanderschueren, D., & Antonio, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010021 · Cited by 101
Advances in stem cell research for the treatment of primary hypogonadism
Li, L., & Papadopoulos, V. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00480-2 · Cited by 40
Non-testosterone management of male hypogonadism: an examination of the existing literature
Krzastek, S. C., & Smith, R. P. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.11.16 · Cited by 33
“GnRH administration requires the use of a continuous infusion pump to titrate GnRH levels to mimic the pulsatile release of GnRH from the hypothalamus, and this treatment modality is still considered experimental (67).”
BackgroundMethod
Metadata
- Authors
- Carrasquillo, R., Chu, K., & Ramasamy, R.
- Affiliations
- University of Miami (US)
- Corresponding author
- Carrasquillo, Robert
- Venue
- Current Urology Reports
- Published
- 2018-06-09
- Volume
- 19
- Issue
- 8
- Pages
- 63-63
- ISSN
- 1527-2737 (ISSN-L)
- 1534-6285
- OpenAlex
- W2805473064
- Cited by
- 31
- References
- 70
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 4
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Urology Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- male hypogonadism, androgen deficiency, testosterone replacement therapy, anabolic steroids, selective androgen receptor modulators, selective estrogen receptor modulators, gonadotropins, aromatase inhibitors, male fertility preservation, off-label drug use
- MeSH terms
- Administration, Intranasal, Administration, Oral, Gonadotropins, Humans, Hypogonadism, Male, Testosterone, Hormone Replacement Therapy, Selective Estrogen Receptor Modulators, Testosterone Congeners, Aromatase Inhibitors, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel Therapy for Male Hypogonadism. https://app.cochat.ai/papers/10.1007/s11934-018-0816-x
- The paper
- Carrasquillo, R., Chu, K., & Ramasamy, R. (2018). Novel Therapy for Male Hypogonadism. Current Urology Reports. https://doi.org/10.1007/s11934-018-0816-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.